Catalog No.
RHJ02101
Species reactivity
Human
Host species
Mouse
Isotype
IgG2a, kappa
Clonality
Monoclonal
Target
EPHA10, Ephrin type-A receptor 10
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q5JZY3
Applications
ELISA
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
SAA1491
Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer., PMID:35278434
[Development of a Fundamental Technology to Seek Drug Targets, and Its Application to Cancer Targeting Therapy]., PMID:29962467
Overcoming Multidrug Resistance by Codelivery of MDR1-Targeting siRNA and Doxorubicin Using EphA10-Mediated pH-Sensitive Lipoplexes: In Vitro and In Vivo Evaluation., PMID:29798663
Anti-EphA10 antibody-conjugated pH-sensitive liposomes for specific intracellular delivery of siRNA., PMID:27574425
[Challenge to the Development of Molecular Targeted Therapy against a Novel Target Candidate Identified by Antibody Proteomics Technology]., PMID:26831784
A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy., PMID:26678395
Generation and characterization of a bispecific diabody targeting both EPH receptor A10 and CD3., PMID:25528586
Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers., PMID:24946238
Eph receptor A10 has a potential as a target for a prostate cancer therapy., PMID:24924629